Emerging Opportunity: Bluechip Bull Run
Here is the latest financial fact sheet of IND. SWIFT. For more details, see the IND. SWIFT quarterly results and IND. SWIFT share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -2.0 |
No. of shares | m | 54.16 |
1 Week | % | 3.8 |
1 Month | % | 28.6 |
1 Year | % | 181.1 |
52 week H/L | Rs | 31.1/7.8 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
IND. SWIFT EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 11 | 6 | 5 | 19 | 15 | |
Low | Rs | 5 | 2 | 2 | 4 | 7 | |
Sales per share (Unadj.) | Rs | 53.4 | 60.8 | 65.7 | 73.4 | 75.9 | |
Earnings per share (Unadj.) | Rs | 1.5 | -3.5 | -5.5 | -3.7 | 4.8 | |
Diluted earnings per share | Rs | 1.5 | -3.5 | -5.5 | -3.7 | 4.8 | |
Cash flow per share (Unadj.) | Rs | 7.8 | 2.7 | 0.5 | 2.2 | 10.1 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | -125.0 | -131.7 | -128.4 | -133.0 | -130.1 | |
Adj. book value per share | Rs | -124.9 | -131.7 | -128.3 | -133.0 | -130.1 | |
Shares outstanding (eoy) | m | 54.16 | 54.16 | 54.16 | 54.16 | 54.16 | |
Price / Sales ratio | x | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | |
Avg P/E ratio | x | 5.3 | -1.1 | -0.6 | -3.0 | 2.2 | |
P/CF ratio (eoy) | x | 1.0 | 1.5 | 6.4 | 5.1 | 1.0 | |
Price / Book Value ratio | x | -0.1 | 0 | 0 | -0.1 | -0.1 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 433 | 216 | 184 | 610 | 572 | |
Total wages/salary | Rs m | 463 | 489 | 512 | 578 | 637 |
IND. SWIFT INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 2,890 | 3,295 | 3,561 | 3,977 | 4,110 | |
Other income | Rs m | 84 | 224 | 152 | 235 | 119 | |
Total revenues | Rs m | 2,975 | 3,519 | 3,713 | 4,213 | 4,228 | |
Gross profit | Rs m | 375 | 297 | 402 | 461 | 1,026 | |
Depreciation | Rs m | 340 | 336 | 327 | 321 | 287 | |
Interest | Rs m | 38 | 352 | 522 | 572 | 598 | |
Profit before tax | Rs m | 82 | -167 | -295 | -196 | 260 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 0 | 25 | 3 | 4 | 0 | |
Profit after tax | Rs m | 82 | -191 | -298 | -200 | 260 | |
Gross profit margin | % | 13.0 | 9.0 | 11.3 | 11.6 | 25.0 | |
Effective tax rate | % | 0 | -14.8 | -1.1 | -2.1 | 0 | |
Net profit margin | % | 2.8 | -5.8 | -8.4 | -5.0 | 6.3 |
IND. SWIFT BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 1,935 | 2,286 | 2,652 | 2,424 | 2,734 | |
Current liabilities | Rs m | 6,159 | 6,541 | 7,062 | 7,180 | 9,363 | |
Net working cap to sales | % | -146.1 | -129.1 | -123.9 | -119.6 | -161.3 | |
Current ratio | x | 0.3 | 0.3 | 0.4 | 0.3 | 0.3 | |
Inventory Days | Days | 144 | 114 | 153 | 133 | 115 | |
Debtors Days | Days | 954 | 1,043 | 1,107 | 832 | 929 | |
Net fixed assets | Rs m | 4,049 | 3,730 | 4,064 | 3,893 | 3,758 | |
Share capital | Rs m | 108 | 108 | 108 | 108 | 108 | |
"Free" reserves | Rs m | -6,876 | -7,240 | -7,060 | -7,312 | -7,155 | |
Net worth | Rs m | -6,767 | -7,131 | -6,952 | -7,203 | -7,047 | |
Long term debt | Rs m | 6,447 | 6,442 | 6,442 | 6,193 | 4,031 | |
Total assets | Rs m | 5,984 | 6,016 | 6,716 | 6,318 | 6,492 | |
Interest coverage | x | 3.2 | 0.5 | 0.4 | 0.7 | 1.4 | |
Debt to equity ratio | x | -1.0 | -0.9 | -0.9 | -0.9 | -0.6 | |
Sales to assets ratio | x | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | |
Return on assets | % | 2.0 | 2.7 | 3.3 | 5.9 | 13.2 | |
Return on equity | % | -1.2 | 2.7 | 4.3 | 2.8 | -3.7 | |
Return on capital | % | -37.3 | -26.9 | -44.5 | -37.2 | -28.4 | |
Exports to sales | % | 69.5 | 69.5 | 74.2 | 73.7 | 68.8 | |
Imports to sales | % | 3.2 | 4.1 | 5.0 | 6.0 | 5.3 | |
Exports (fob) | Rs m | 2,010 | 2,290 | 2,643 | 2,932 | 2,827 | |
Imports (cif) | Rs m | 93 | 134 | 176 | 239 | 217 | |
Fx inflow | Rs m | 2,034 | 2,344 | 2,682 | 2,996 | 2,947 | |
Fx outflow | Rs m | 137 | 187 | 260 | 283 | 313 | |
Net fx | Rs m | 1,897 | 2,157 | 2,422 | 2,713 | 2,634 |
IND. SWIFT CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 428 | 346 | 832 | 502 | 730 | |
From Investments | Rs m | -137 | -114 | -167 | -184 | -293 | |
From Financial Activity | Rs m | -130 | -262 | -542 | -446 | -466 | |
Net Cashflow | Rs m | 160 | -30 | 122 | -128 | -29 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: S R Mehta | COMP SEC: Amrender Kumar Yadav | YEAR OF INC: 1986 | BSE CODE: 524652 | FV (Rs): 2 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare IND. SWIFT With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the negative note, Indian share markets Slipped further as the session progressed and ended the day weak.